Projected 2024 revenue for top drugs approved U.S. 2018
This statistic displays the projected 2022 revenue for selected top drugs approved in the U.S. in 2018. Biktarvy, developed by Gilead Sciences, is estimated to generate some five billion U.S. dollars in annual revenue in 2024.